Up to date, the limited information relative to the postranscriptional regulation of SND1 identifies SND1 transcript as a target of miR-184 in malignant gliomas and breast cancer [21, 57] and miR-361-5p in colorectal and gastric cancer [58] and links miRNAs suppression with SND1 upregulation and cancer development and progression. This evidence concerns the gene SND1 and cancer.